What researchers published on Glioblastoma
5,266 papers, newest first.
Showing 20 of 5,266
Not labelled yetChromosome 14q loss is associated with adverse survival and a distinct transcriptional phenotype in IDH-wildtype glioblastoma.Journal of neuro-oncology
Not labelled yetMolecular profiling uncovers KCa2.3 as key driver of pacemaker cells in glioblastoma.Neuro-oncology
Not labelled yetDisulfidptosis-Driven Immune-Activated Multimodal Therapy for Glioblastoma with Systemic Safety Control.ACS nano
Not labelled yetEnhancing Apoptosis in Glioblastoma Through Hybrid Nanoparticle-Mediated Resveratrol Delivery: In Vitro Cytotoxicity and in Vivo Pharmacokinetic Study.Advanced pharmaceutical bulletin
ReviewPatient-Derived Glioblastoma Organoids for AI-Guided Prediction of Therapeutic Response.Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Not labelled yetOxajulolidinyl-Induced Molecular Twisting in Aza-BODIPY Nanoplatform for NIR-Triggered Synergistic Phototherapy of Glioblastoma.Small (Weinheim an der Bergstrasse, Germany)
Not labelled yetExploiting redox vulnerability to sensitize glioblastoma cells to mirdametinib through oxidative damage and cell cycle re-programming.Molecular biology reports
ReviewCurrent landscape of small molecule MGMT expression inhibitors as potential resistance reversers for glioblastoma.Future medicinal chemistry
ReviewMacrophage immunometabolism in glioblastoma: from microglial reprogramming to B cell dysfunction.Frontiers in immunology
Not labelled yetCOX4-1 Silencing Impairs Mitochondrial Function and Suppresses Malignant Phenotypes in Glioblastoma Cells.The Yale journal of biology and medicine
Not labelled yetTargeting of STEAP3 by a selenium D-π-A photosensitizer that activates ferroptosis.Proceedings of the National Academy of Sciences of the United States of America
Not labelled yetThe transcription factor YY1 prevents copper ionophore-induced cell death by interacting with Sp1 and MTF1 in glioblastoma.Acta biochimica et biophysica Sinica
Not labelled yetSNX4 promotes glioblastoma progression through the TGFβ1/Smad signaling pathway and represents a potential therapeutic target.Journal of translational medicine
Not labelled yetEfficacy of allogeneic B7-H3 CAR γδ T cells with comparative target assessment across preclinical models in glioblastoma.BMC medicine
Not labelled yetA multi-task deep learning framework incorporating tumor morphology for MRI-based MGMT methylation prediction in glioblastoma.BMC medical imaging
Not labelled yetIntegrated computational analyses reveal multi-target kinase modulation as a potential mechanism underlying teriflunomide action in glioblastoma: network evidence for estrogen-associated pathway crosstalk.BMC cancer
Not labelled yetSelf-Crosslinked Albumin Nanoparticles for Targeted Doxorubicin Delivery in Glioblastoma.Biomacromolecules
Not labelled yetHierarchical coordination-assembled biomimetic nanoplatform for ultrasound-activated mitochondrial stress amplification in glioblastoma therapy.Colloids and surfaces. B, Biointerfaces
ReviewImmunotherapy for gliomas: from checkpoint blockade to vaccines, cellular therapy, local immune engineering and combinations.Current opinion in neurology
ReviewInterconnected roles of cellular senescence and the immune microenvironment in tumor progression: from pan-cancer mechanisms to glioblastoma implications.Cell death discovery